Adverts

Open Access Articles- Top Results for Omiloxetine

Omiloxetine

</th></tr></th></tr>
Omiloxetine
File:Omiloxetine.svg
Systematic (IUPAC) name
2-[(3R,4S)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-piperidinyl]-1-(4-fluorophenyl)ethanone
Clinical data
Identifiers
176894-09-0
None
PubChem CID 3047803
ChemSpider 2310120
UNII H8YI0SSF7B
ChEMBL CHEMBL2105290
Chemical data
Formula C27H25F2NO4
465.489 g/mol
Physical data
Density 1.3±0.1 g/cm3
Melting point Script error: No such module "convert".
Boiling point Script error: No such module "convert".
0.0015 mg/mL (20 °C)

Omiloxetine (INN) was a selective serotonin reuptake inhibitor drug candidate that was under development by the Spanish pharmaceutical company, Ferrer Internacional, until 2005.[1][2]

References

  1. ^ Terencio, Jose (2005-12-05). "Omiloxetine - Ferrer licensing offer, worldwide". R & D Focus Drug News. Retrieved 2012-05-19. 
  2. ^ De Lecea, Dr Carlos (2003-12-08). "Omiloxetine - Ferrer partnering opportunity, worldwide Ferrer preclinical data". R & D Focus Drug News. Retrieved 2012-05-19. 


Lua error in package.lua at line 80: module 'Module:Buffer' not found.